Lee, M., Cho, H. J., Hong, J. Y., Lee, J., Park, S. H., Park, J. O., . . . Kim, S. T. (2020). Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment. Ther Adv Med Oncol.
Chicago Style CitationLee, Min-Sang, et al. "Clinical and Molecular Distinctions in Patients With Refractory Colon Cancer Who Benefit From Regorafenib Treatment." Ther Adv Med Oncol 2020.
Cita MLALee, Min-Sang, et al. "Clinical and Molecular Distinctions in Patients With Refractory Colon Cancer Who Benefit From Regorafenib Treatment." Ther Adv Med Oncol 2020.
Atenció: Aquestes cites poden no estar 100% correctes.